<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-06T00:02:35Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/75197" metadataPrefix="ese">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/75197</identifier><datestamp>2025-03-03T20:01:13Z</datestamp><setSpec>com_10324_1181</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1387</setSpec></header><metadata><europeana:record xmlns:europeana="http://www.europeana.eu/schemas/ese/" xmlns:confman="org.dspace.core.ConfigurationManager" xmlns:doc="http://www.lyncode.com/xoai" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.europeana.eu/schemas/ese/ http://www.europeana.eu/schemas/ese/ESE-V3.4.xsd">
<dc:title>Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems</dc:title>
<dc:creator>Bahillo Curieses, María del Pilar</dc:creator>
<dc:creator>Fernández Velasco, Pablo</dc:creator>
<dc:creator>Pérez López, Paloma</dc:creator>
<dc:creator>Vidueira Martínez, Ana María</dc:creator>
<dc:creator>Nieto de la Marca, María de la O</dc:creator>
<dc:creator>Díaz Soto, Gonzalo</dc:creator>
<dc:subject>Type 1 diabetes</dc:subject>
<dc:subject>Time in range</dc:subject>
<dc:subject>Time in tight range</dc:subject>
<dc:subject>Advanced hybrid closed loop</dc:subject>
<dc:subject>Glucose variability</dc:subject>
<dc:subject>32 Ciencias Médicas</dc:subject>
<dc:description>Producción Científica</dc:description>
<dc:description>Purpose To analyze the time in tight range (TITR), and its relationship with other glucometric parameters in patients with&#xd;
type 1 diabetes (T1D) treated with advanced hybrid closed-loop (AHCL) systems.&#xd;
Methods A prospective observational study was conducted on pediatric and adult patients with T1D undergoing treatment&#xd;
with AHCL systems for at least 3 months. Clinical variables and glucometric parameters before and after AHCL initiation&#xd;
were collected.&#xd;
Results A total of 117 patients were evaluated. Comparison of metabolic control after AHCL initiation showed significant&#xd;
improvements in HbA1c (6.9 ± 0.9 vs. 6.6 ± 0.5%, p &lt; 0.001), time in range (TIR) (68.2 ± 11.5 vs. 82.5 ± 6.9%, p &lt; 0.001),&#xd;
TITR (43.7 ± 10.8 vs. 57.3 ± 9.7%, p &lt; 0.001), glucose management indicator (GMI) (6.9 ± 0.4 vs. 6.6 ± 0.3%, p &lt; 0.001),&#xd;
time below range (TBR) 70–54 mg/dl (4.3 ± 4.5 vs. 2.0 ± 1.4%, p &lt; 0.001), and time above range (TAR) > 180 mg/dl&#xd;
(36.0 ± 7.6 vs. 15.1 ± 6.4%, p &lt; 0.001). Coefficient of variation (CV) also improved (36.3 ± 5.7 vs. 30.6 ± 3.7, p &lt; 0.001),&#xd;
while time between 140–180 mg/dl remained unchanged. In total, 76.3% achieved TITR > 50% (100% pediatric). Corre-&#xd;
lation analysis between TITR and TIR and GRI showed a strong positive correlation, modified by glycemic variability.&#xd;
Conclusions AHCL systems achieve significant improvements in metabolic control (TIR > 70% in 93.9% patients). The&#xd;
increase in TIR was not related to an increase in TIR 140–180 mg/dl. Despite being closely related to TIR, TITR allows for a&#xd;
more adequate discrimination of the achieved control level, especially in a population with good initial metabolic control.&#xd;
The correlation between TIR and TITR is directly influenced by the degree of glycemic variability.</dc:description>
<dc:description>Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCLE</dc:description>
<dc:date>2025-03-03T10:09:04Z</dc:date>
<dc:date>2025-03-03T10:09:04Z</dc:date>
<dc:date>2024</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>Endocrine, 2024, vol. 86, n. 2, p. 539-545</dc:identifier>
<dc:identifier>https://uvadoc.uva.es/handle/10324/75197</dc:identifier>
<dc:identifier>10.1007/s12020-024-03881-6</dc:identifier>
<dc:identifier>539</dc:identifier>
<dc:identifier>2</dc:identifier>
<dc:identifier>545</dc:identifier>
<dc:identifier>Endocrine</dc:identifier>
<dc:identifier>86</dc:identifier>
<dc:identifier>1559-0100</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>https://link.springer.com/article/10.1007/s12020-024-03881-6</dc:relation>
<dc:rights>Atribución 4.0 Internacional</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>© 2024 The Author(s)</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>Springer</dc:publisher>
<europeana:object>https://uvadoc.uva.es/bitstream/10324/75197/4/Utility-time-tight-range.pdf.jpg</europeana:object>
<europeana:provider>Hispana</europeana:provider>
<europeana:type>TEXT</europeana:type>
<europeana:rights>http://creativecommons.org/licenses/by/4.0/</europeana:rights>
<europeana:dataProvider>UVaDOC. Repositorio Documental de la Universidad de Valladolid</europeana:dataProvider>
<europeana:isShownAt>https://uvadoc.uva.es/handle/10324/75197</europeana:isShownAt>
</europeana:record></metadata></record></GetRecord></OAI-PMH>